Donor autologous stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy22

Stem Cells Hematopoietic Stem Cells Autografts Embryonic Stem Cells Adult Stem Cells Mesenchymal Stromal Cells Pluripotent Stem Cells Bone Marrow T-Lymphocytes Neural Stem Cells Bone Marrow Cells Cells, Cultured Induced Pluripotent Stem Cells Multipotent Stem Cells Antilymphocyte Serum Fetal Stem Cells Fetal Blood Spermatogonia Neoplastic Stem Cells Allografts Plant Stems Blood Cells

Organisms4

Transplantation Chimera Mice, Inbred C57BL Cytomegalovirus Mice, SCID

Diseases55

Multiple Myeloma Hodgkin Disease Lymphoma, Non-Hodgkin Recurrence Graft vs Host Disease Hematologic Neoplasms Lymphoma, Mantle-Cell Amyloidosis Lymphoma, Follicular Lymphoma, T-Cell, Peripheral Lymphoma Lymphoma, Large B-Cell, Diffuse Neoplasm, Residual Leukemia, Myeloid, Acute Enteropathy-Associated T-Cell Lymphoma Myelodysplastic Syndromes Lymphoma, B-Cell Leukemia, Plasma Cell Neoplasms, Second Primary Leukemia, Myeloid Leukemia Acute Disease Neoplasm Recurrence, Local Neutropenia Hepatic Veno-Occlusive Disease Precursor Cell Lymphoblastic Leukemia-Lymphoma Disease Progression Lymphoma, AIDS-Related Neuroblastoma Hematologic Diseases Neoplasms Stomatitis Cytomegalovirus Infections Leukemia, Myelogenous, Chronic, BCR-ABL Positive Anemia, Aplastic Breast Neoplasms Mucositis Infection Severe Combined Immunodeficiency Lymphoproliferative Disorders Medulloblastoma Chromosome Aberrations Opportunistic Infections Leukemia, Lymphocytic, Chronic, B-Cell Postoperative Complications Blood Group Incompatibility Central Nervous System Neoplasms Thrombocytopenia Disease Models, Animal Paraproteinemias Liver Failure Chronic Disease Bronchiolitis Obliterans Roseolovirus Infections Mycoses

Chemicals and Drugs49

Melphalan Myeloablative Agonists Etoposide Cytarabine Cyclophosphamide Carmustine Vincristine Thiotepa Busulfan Boronic Acids Dexamethasone Pyrazines Antibodies, Monoclonal, Murine-Derived Antigens, CD34 Doxorubicin Thalidomide Antineoplastic Agents, Alkylating Prednisone Ifosfamide Podophyllotoxin Granulocyte Colony-Stimulating Factor Antineoplastic Agents Idarubicin Mitoxantrone Immunosuppressive Agents Keratins, Type II Antibodies, Monoclonal Carboplatin Immunoglobulin Light Chains Vidarabine HLA Antigens Cisplatin Antilymphocyte Serum Immunoconjugates Stem Cell Factor Bleomycin Cyclosporine Recombinant Proteins Minor Histocompatibility Antigens Methotrexate Antigens, CD Tacrolimus Antigens, CD20 Prednisolone Immunologic Factors Biological Markers Nitrogen Mustard Compounds Myeloma Proteins Antibodies, Neoplasm

Analytical, Diagnostic and Therapeutic Techniques and Equipment93

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Remission Induction Treatment Outcome Salvage Therapy Disease-Free Survival Bone Marrow Transplantation Hematopoietic Stem Cell Mobilization Survival Rate Bone Marrow Purging Whole-Body Irradiation Retrospective Studies Survival Analysis Liver Transplantation Prognosis Follow-Up Studies Mesenchymal Stem Cell Transplantation Leukapheresis Induction Chemotherapy Cord Blood Stem Cell Transplantation Maintenance Chemotherapy Cell Transplantation Kidney Transplantation Infusions, Spinal Histocompatibility Testing Blood Component Removal Prospective Studies Feasibility Studies Fatal Outcome Heart Transplantation Life Tables Radioimmunotherapy Risk Factors Lung Transplantation Immunotherapy Drug Administration Schedule Organ Transplantation Blood Transfusion, Autologous Transplantation, Isogeneic Lymphocyte Transfusion Flow Cytometry Transplantation Kaplan-Meier Estimate Clinical Trials as Topic Immunosuppression Islets of Langerhans Transplantation Treatment Failure Lymphocyte Depletion Pilot Projects Neoplasm Staging Cell Separation Positron-Emission Tomography Pancreas Transplantation Immunophenotyping Platelet Count Predictive Value of Tests Cell Culture Techniques Donor Selection Transplantation, Heterologous Immunomagnetic Separation Severity of Illness Index Randomized Controlled Trials as Topic Stem Cell Research Fetal Tissue Transplantation Cell- and Tissue-Based Therapy Multivariate Analysis Leukocyte Count Proportional Hazards Models Transplantation, Heterotopic Disease Models, Animal Cohort Studies Colony-Forming Units Assay Platelet Transfusion Immunotherapy, Adoptive Heart-Lung Transplantation Polymerase Chain Reaction Lymphocyte Count Leukocyte Transfusion Incidence Radiotherapy Reverse Transcriptase Polymerase Chain Reaction Cell Count Skin Transplantation Blood Cell Count Drug Therapy Coculture Techniques Tissue Transplantation

Psychiatry and Psychology1

Phenomena and Processes26

Graft Survival Time Factors Histocompatibility Cell Differentiation Hematopoiesis Graft vs Leukemia Effect Transplantation Immunology Graft Rejection Stem Cell Niche Graft vs Tumor Effect Chimerism Dose-Response Relationship, Drug Cell Lineage Platelet Count Cell Proliferation Regeneration Transplantation Tolerance Immunocompromised Host Chromosome Aberrations Virus Activation Leukocyte Count Cell Survival Lymphocyte Count Cell Count Blood Cell Count Phenotype

Disciplines and Occupations2

Stem Cell Research Regenerative Medicine

Anthropology, Education, Sociology and Social Phenomena2

Siblings Quality of Life

Humanities1

Quality of Life

Information Science4

Survival Rate Fatal Outcome Life Tables Incidence

Named Groups5

Tissue Donors Living Donors Blood Donors Siblings Unrelated Donors

Health Care25

Treatment Outcome Disease-Free Survival Survival Rate Retrospective Studies Survival Analysis Follow-Up Studies Prospective Studies Feasibility Studies Fatal Outcome Life Tables Risk Factors Kaplan-Meier Estimate Clinical Trials as Topic Treatment Failure Pilot Projects Age Factors Predictive Value of Tests Donor Selection Severity of Illness Index Randomized Controlled Trials as Topic Tissue and Organ Procurement Multivariate Analysis Proportional Hazards Models Cohort Studies Incidence

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Multiple Myeloma Melphalan Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Remission Induction Treatment Outcome Stem Cells Salvage Therapy Disease-Free Survival Hodgkin Disease Myeloablative Agonists Etoposide Lymphoma, Non-Hodgkin Recurrence Cytarabine Graft vs Host Disease Cyclophosphamide Carmustine Bone Marrow Transplantation Hematopoietic Stem Cell Mobilization Vincristine Survival Rate Bone Marrow Purging Thiotepa Hematologic Neoplasms Lymphoma, Mantle-Cell Whole-Body Irradiation Amyloidosis Retrospective Studies Survival Analysis Tissue Donors Hematopoietic Stem Cells Busulfan Graft Survival Boronic Acids Dexamethasone Pyrazines Liver Transplantation Antibodies, Monoclonal, Murine-Derived Lymphoma, Follicular Autografts Antigens, CD34 Prognosis Lymphoma, T-Cell, Peripheral Doxorubicin Follow-Up Studies Thalidomide Antineoplastic Agents, Alkylating Mesenchymal Stem Cell Transplantation Prednisone Leukapheresis Ifosfamide Time Factors Podophyllotoxin Granulocyte Colony-Stimulating Factor Lymphoma Transplantation Chimera Induction Chemotherapy Lymphoma, Large B-Cell, Diffuse Neoplasm, Residual Cord Blood Stem Cell Transplantation Maintenance Chemotherapy Cell Transplantation Kidney Transplantation Leukemia, Myeloid, Acute Embryonic Stem Cells Enteropathy-Associated T-Cell Lymphoma Antineoplastic Agents Myelodysplastic Syndromes Lymphoma, B-Cell Infusions, Spinal Leukemia, Plasma Cell Idarubicin Adult Stem Cells Histocompatibility Testing Neoplasms, Second Primary Mitoxantrone Immunosuppressive Agents Blood Component Removal Living Donors Prospective Studies Histocompatibility Cell Differentiation Keratins, Type II Antibodies, Monoclonal Feasibility Studies Mesenchymal Stromal Cells Leukemia, Myeloid Fatal Outcome Heart Transplantation Life Tables Hematopoiesis Carboplatin Radioimmunotherapy

No FAQ available that match "donor autologous stem cell transplantation"